Although their diagnosis about what ails U.S. healthcare and their prescription for remedying it are almost entirely from ...

Gomekli is the second ever FDA-approved treatment for rare tumor disease, NF1-PN and the first to be approved for both adult ...

Several weeks after reporting positive results for nerandomilast for idiopathic pulmonary fibrosis, Boehringer Ingelheim reported positive results from a similar phase 3 trial assessing its PDE4B ...

Inhalon’s inhaled antibody therapy aims to address this need, the release said. Its RSV candidate is part of a more broad effort to develop therapies that deliver therapeutic antibodies directly to ...

The group released a statement today expressing that they are eager to work with Robert F. Kennedy Jr. to eradicate HIV when ...

Risk factors for secondary skin cancer after blood or marrow transplant include those who had treatment with a monoclonal ...

The second part of our conversation with Craig Burton, MBA, executive director of the Biosimilars Council, a trade and ...

Positive HIV status as well as socioeconomic disadvantages, not breastfeeding, are associated with infant length and birth ...

The updated label allows physicians to prescribe Izervay without a limitation on duration for patients with geographic ...

Although CAR T-cell therapies have been found effective against certain difficult-to-treat malignancies, they are not devoid of safety concerns.

Vaccines are not mentioned in the order but there are references to overmedication of children and undue industry influence.

An expert discusses the current understanding of corticosteroids in managing pulmonary fibrosis and how it has evolved in ...